Search database
LIST OPTIONS
Filter
8
Filtered Results: 8
Text search: Indonesian Rheumatology Association
Featured
Language
Document type
Guidelines
3
No document type
3
Studies & Reports
2
Countries / Regions
South–East Asia Region
1
Indonesia
1
Authors & Publishers
World Health Organisation (WHO)
2
GBD 2019 Blindness and Vision Impairment Collaborators
1
Indonesian Rheumatology Association
1
The Lancet
1
World Health Organization - Regional Office for South-East Asia
1
World Health Organization WHO
1
World Health Organization, Regional Office South-East Asia
1
Publication Years
Category
TB
2
NCD
1
Guidelines
1
NTDs & Others
1
Disease Prevention & Control
1
Toolboxes
Adults
1
Public Health
1
Global Impact: Socio-economic, health services, TB & HIV
1
Essential Medicines & Medical Devices
1
Long COVID/ Post-COVID Syndrome
1
HIV &TB
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Drug resistant TB
1
General
1
Vision Loss & Blindness
1
Chikungunya Prevention & Control
1
TB
1
Diagnosis and Management of Systemic Lupus Erythematosus
The guide is organized into the major types of toxicities, the associated symp-toms, possible offending medications, and the suggested nursing assessments and interventions. Some symptoms (e.g. nausea) may be associated with a num-ber of underlying causes and may be mild, or a symptom of... more
This guideline for the prevention and control of chikungunya fever (CF) is intended for use by all peripheral health workers in the Region and is based on the strategy outlined above. This document will focus mainly on preventing, predicting and detecting outbreaks, and after detection, investig... more
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19 condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition may be applicable for children. It is important to understand the frequency, characteristics ... more
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys... more